5BA Prospective trial of endocrine therapy alone in patients with estrogen-receptor positive, HER2-negative, node-negative breast cancer: Results of the TAILORx low risk registry. (September 2015) - Sparano, J.; Gray, R.; Zujewski, J.A.; Makower, D.; Pritchard, K.; Albain, K.; Hayes, D.; Geyer, C.; Dees, C.; Perez, E.; Keane, M.; Vallejos, C.; et al.